Cardiovascular disease remains the leading global killer. Still, too many late-stage cardiology trials stumble, not for lack of biology, but because episodic, clinic-bound measures miss what matters ...

The introduction of AI across an expansive ecosystem of endpoints poses unique challenges for IT buyers and directors.

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...